Previous 10 |
All signs point towards an imminent withdrawal of central bank stimulus, globally. Meanwhile, the U.S. economy is headed for one of the largest fiscal cliffs ever. Global growth is slowing even before massive stimulus withdrawal. For further details see: Prepare For Turb...
Psychedelics stocks could be the next big thing. For investors who prefer to buy a basket of stocks, there's now a new exchange-traded fund that focuses largely on psychedelics stocks -- the Defiance Next Gen Altered Experience ETF (NYSEMKT: PSY) . In this Motley Fool Live ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It wasn’t long before marijuana was considered a taboo. Emerging science, however, has altered customer perceptions and has paved a path for its legalization. As a result, the global legal marijuana market continues ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips PSY (NYSEARCA: PSY ) is getting extra attention on Monday as investors seek out investments in the psychedelic medical market. Source: luckakcul / Shutterstock.com Here’s everything investors interested...
Shares of Seelos Therapeutics (NASDAQ: SEEL) were jumping 11.4% higher as of 12:28 p.m. EDT on Tuesday. The gain came after the company announced that it has been included in the Defiance Next Gen Altered Experience ETF (NYSEMKT: PSY) . This is the first exchange-traded fund...
Seelos Therapeutics Announces its Inclusion in the First U.S. Listed Exchange Traded Fund (ETF) Focused on Psychedelics - ETF Trades on the New York Stock Exchange Under the Symbol PSY PR Newswire NEW YORK , June 1, 2021 /PRNewswire/ -- Seelos Therapeutics, I...
News, Short Squeeze, Breakout and More Instantly...
Defiance Next Gen Altered Experience ETF Company Name:
PSY Stock Symbol:
NYSE Market:
The Board of Trustees of ETF Series Solutions, upon a recommendation from Defiance ETFs, LLC, the investment adviser to the Defiance Next Gen Altered Experience ETF, and the Defiance Next Gen SPAC Derived ETF (each, a “Fund” and collectively, the “Funds”), ...
Renewed interest in psychedelics in both public and scientific spaces has increased investor interest in psychedelic stocks. The psychedelic market is projected to achieve a valuation of $10.7 billion by 2027 , and investors are looking to cash in on the industry before it is satura...
Psychedelics stocks could be the next big thing. For investors who prefer to buy a basket of stocks, there's now a new exchange-traded fund that focuses largely on psychedelics stocks -- the Defiance Next Gen Altered Experience ETF (NYSEMKT: PSY) . In this Motley Fool Live ...